Elequin Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-67
Closed -$1.01K – 999
2026
Q2
$1.01K Buy
67
+43
+179% +$751 ﹤0.01% 573
2026
Q1
$460 Sell
24
-66
-73% -$1.43K ﹤0.01% 581
2025
Q4
$1.98K Buy
+90
New +$1.62K ﹤0.01% 358
2025
Q3
– Sell
-54
Closed -$1.01K – 377
2025
Q2
$1.01K Buy
+54
New +$1.07K ﹤0.01% 340
2025
Q1
– Sell
-6
Closed -$216 – 629
2024
Q4
$216 Sell
6
-115
-95% -$3.89K ﹤0.01% 474
2024
Q3
$5.13K Buy
+121
New +$5.13K ﹤0.01% 291
2024
Q2
– Sell
-7
Closed -$248 – 349
2024
Q1
$248 Buy
+7
New +$188 ﹤0.01% 219
2023
Q4
– Sell
-1
Closed -$21 – 489
2023
Q3
$21 Sell
1
-16
-94% -$439 ﹤0.01% 384
2023
Q2
$417 Buy
+17
New +$547 ﹤0.01% 500
2022
Q3
– Sell
-9
Closed -$1K – 671
2022
Q2
$1K Sell
9
-15
-63% -$1.23K ﹤0.01% 373
2022
Q1
$3K Buy
24
+7
+41% +$817 ﹤0.01% 246
2021
Q4
$3K Buy
+17
New +$2.3K ﹤0.01% 24

Other funds holding TNDM

Elequin Capital's TNDM Position: Q3 2026 in Review

Elequin Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2026, closing a stake of 67 shares — an estimated $1.01K sold.

Elequin Capital first reported a position in TNDM in Q4 2021 and held it in 12 quarters. The position peaked at $5.13K in Q3 2024. 267 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Elequin Capital reported no remaining Tandem Diabetes Care position as of Q3 2026 after selling out during the quarter.
  • Elequin Capital sold 67 Tandem Diabetes Care shares in Q3 2026, an estimated $1.01K.
  • Elequin Capital first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 12 quarters.
  • Elequin Capital's Tandem Diabetes Care position peaked at $5.13K in Q3 2024.
  • 267 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Elequin Capital's 13F filing for Q3 2026, filed 13 Nov 2026.